Form 4 filings across 2 companies. Net figures count open-market buys and sales only. EDGAR profile ↗
Lifetime net: -$5.9M
Reported holding is the most recent post-transaction share count on a Table I row.
How quickly this filer reports. Section 16 allows two business days from the transaction.
All 5 filings we hold were filed within the two-business-day deadline.
Counted in business days from the transaction date, or the deemed execution date where the filing reports one, excluding weekends and federal holidays. How this is measured · All late filings
The 8 most recent Form 4 transactions.
| Theravance Biopharma, Inc. |
| SSELL |
| 37,799 |
| $17.00 |
| $642.6K |
| -0.4% |
| Open the original filing on SEC.gov |
| Jul 1 | STGW | Stagwell Inc | AGRANT | 2,691 | $7.43 | $20K | +1.6% | Open the original filing on SEC.gov |
| Jun 30 | TBPH | Theravance Biopharma, Inc. | SSELL | 25,027 | $17.13 | $428.8K | -0.3% | Open the original filing on SEC.gov |
| Jun 29 | TBPH | Theravance Biopharma, Inc. | SSELL | 273,871 | $17.23 | $4.7M | -2.9% | Open the original filing on SEC.gov |
| Jun 11 | STGW | Stagwell Inc | AGRANT | 22,970 | — | — | +15.8% | Open the original filing on SEC.gov |
| Apr 1 | STGW | Stagwell Inc | AGRANT | 3,180 | $6.29 | $20K | +2.2% | Open the original filing on SEC.gov |